374 related articles for article (PubMed ID: 35455438)
1. Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives.
Manners N; Priya V; Mehata AK; Rawat M; Mohan S; Makeen HA; Albratty M; Albarrati A; Meraya AM; Muthu MS
Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455438
[TBL] [Abstract][Full Text] [Related]
2. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
3. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Muthu MS; Leong DT; Mei L; Feng SS
Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
[TBL] [Abstract][Full Text] [Related]
4. Chemically Modified Natural Polymer-Based Theranostic Nanomedicines: Are They the Golden Gate toward a
Jaymand M
ACS Biomater Sci Eng; 2020 Jan; 6(1):134-166. PubMed ID: 33463213
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
7. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease.
Chen F; Liu Q; Xiong Y; Xu L
Int J Nanomedicine; 2021; 16():4225-4237. PubMed ID: 34188471
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Managing Atherosclerosis via Nanomedicine.
Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
Small; 2018 Jan; 14(4):. PubMed ID: 29239134
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis.
Priya V; Viswanadh MK; Mehata AK; Jain D; Singh SK; Muthu MS
Nanomedicine (Lond); 2021 Jun; 16(13):1153-1176. PubMed ID: 33973818
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.
Cheng J; Huang H; Chen Y; Wu R
Adv Sci (Weinh); 2023 Dec; 10(36):e2304294. PubMed ID: 37897322
[TBL] [Abstract][Full Text] [Related]
11. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
[TBL] [Abstract][Full Text] [Related]
13. Aptamers and their applications in nanomedicine.
Sun H; Zu Y
Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics.
Samridhi ; Setia A; Mehata AK; Priya V; Pradhan A; Prasanna P; Mohan S; Muthu MS
Nanotheranostics; 2024; 8(2):127-149. PubMed ID: 38328614
[TBL] [Abstract][Full Text] [Related]
17. Ligand-targeted theranostic nanomedicines against cancer.
Yao VJ; D'Angelo S; Butler KS; Theron C; Smith TL; Marchiò S; Gelovani JG; Sidman RL; Dobroff AS; Brinker CJ; Bradbury ARM; Arap W; Pasqualini R
J Control Release; 2016 Oct; 240():267-286. PubMed ID: 26772878
[TBL] [Abstract][Full Text] [Related]
18. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
19. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities.
Yang P; Ren J; Yang L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
